Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing The post AstraZeneca buys into startup...
Enzolytics Inc (OTCMKTS: ENZC) is making a powerful move up the charts in recent days since reversing off $0.06 support levels, the second time it has...
A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines — Pfizer-BioNTech and Moderna — perform better against the World...
AstraZeneca moved to bolster its COVID-19 portfolio of antibodies on Tuesday with a $157 million licensing deal for experimental therapies developed by...
LA JOLLA, CA—Last year, scientists at Scripps Research and Toscana Life Sciences studied the blood of 14 COVID-19 survivors to find the most potent antibodies...
MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts. This is the finding of a study...
Funding: Medical Research Future Fund, mRNA Victoria, Jack Ma Foundation, IFM Investors, Australian Research Council and National Health and Medical Research...
BioNTech continues to build on the success of the company's mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline...
Uncharacterised and so far rare cases of unexplained severe liver inflammation among young children. These cases of unexplained hepatitis have been appearing...
Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans...
Globally, breakthrough COVID-19 infections among vaccinated people are increasing, raising concerns about the durability of protection against emerging,...
LA JOLLA, CA—Getting sick with a common cold doesn’t make you immune to COVID-19, but a COVID-19 infection might, at least temporarily, boost the number...
Despite the loss of the company's COVID-19 antibody REGEN-COV earlier in 2022, Regeneron posted a positive first quarter driven primarily by sales of...
The mystery of exactly how the SARS-CoV-2 virus infects human lung cells remains largely hidden to experimental scientists. Now, however, the devilish...
Last week I invited 4 deeply experienced biopharma execs to gather for an hour to discuss what they’ve learned over the years about developing drugs....
Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave, but are far less...
How might one gauge the contributions of selected geographical regions to cancer immunotherapy? Initially, one might assess cancer incidence and prevalence...
As new drug modalities and delivery systems continue to evolve, fresh challenges arise, especially for bioprocessing. Here at GEN, we’ve spoken with...
Humanized in vivo and in vitro systems are becoming more clinically relevant and facilitating better decisions earlier in drug development. The post Animal...
AstraZeneca topped off a very busy week with the company's first-quarter 2022 financial report, citing a total of $11.39 billion in revenue, a whopping...
"Some Misinterpretation" - Fauci Flip-Flops: Walks-Back 'End Of Pandemic' Comments Update (0840ET): Having noted the apparent disconnect between...
Fauci Admits "Pandemic Phase" Of COVID Is Over "We are certainly right now in this country out of the pandemic phase," White House Chief...
Scholars from HSE University and the RAS Institute of Bioorganic Chemistry have demonstrated the efficiency of T-cell immune response against the Omicron...
Enzolytics Inc (OTCMKTS: ENZC) is making an explosive move up the charts after the Company announced a progress update and more on its future plans. The...
Some big themes become apparent as you get into the details on the world’s top 15 R&D players, ranked by overall spending in 2021. Bottom line,...
Uncahareistsed and so far rare cases of liver inflammation (hepatitis) have been appearing in low numbers among young children worldwide since January...
Enzolytics Inc (OTCMKTS: ENZC) is easily one of the most exciting stocks currently trading on the OTCQB; trading 3 tenths of a penny over 52-week lows...
Do a person’s antibodies work to block the COVID-19 virus from infecting one’s system? Are these antibodies also capable of blocking emerging variants...
More than 60 signatories sent a letter sent to the FDA’s Robert Califf and Peter Marks on Thursday urging the agency to include a recommendation for...
Despite all the bad news the COVID-19 pandemic brought upon the world, it has helped us gain a better perspective of our readiness to fend off...